Mutation of Arg723Gly in β-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy

Chinese Medical Journal

Volumn 119, Issue 21, 2006, Pages 1785-1789

  Yang, Jun Hua ^a   Zheng, Dong Dong ^b   Dong, Ning Zheng ^a   Yang, Xiang Jun ^a   Song, Jian Ping ^a   Jaing, Ting Bo ^a   Cheng, Xu Jie ^a   Li, Hong Xia ^a   Zhou, Bing Yuan ^a   Zhao, Cai Ming ^a   Jiang, Wen Ping ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Cardiomyopathy; Familial; Genotype; Hypertrophic; Mutation; Myosin heavy chain; Phenotype

Indexed keywords

AMINO ACID; ARGININE; CYTOSINE; GLYCINE; GUANINE; MYOSIN HEAVY CHAIN BETA;

ADOLESCENT; ADULT; AGING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEART ATRIUM ENLARGEMENT; HEART FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SEPTUM DEFECT; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEQUENCE ANALYSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 33751103906     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200611010-00004     Document Type: Article

References (21)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CADIA study: coronary artery risk development in (young) adults. Circulation 1995; 92: 785-789.
2. Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographicanalysis of 8080 adults. Am J Med 2004; 116: 14-18.
3. Ho HH, Lee KL, Lau CP, Tse HF. Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med 2004; 116: 19-23.
4. Wang P, Zou Y, Fu Z, Zhou X, Hui R. MYBPC3 polymorphism is a modifier for expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2005; 329: 796-799.
5. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995; 92:1336-1347.
6. Seidman CE, Seidman JG. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol 1998; 93 Suppl 3: 13-16.
7. Song L, Zou Y, Wang J, Wang Z, Zhen Y, Lou K, et al. Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clinica Chimica Acta 2005; 351: 209-216.
8. Jaenicke T, Diederich KW, Haas W, Schleich J, Lichter P, Pfordt M, et al. The complete sequence of the human beta-myosin heavy chain gene and an analysis of its product. Genomics 1990; 8: 194-206.
9. Liew CC, Sole MJ, Yamauchi-Takihara K, Kellam B, Anderson DH, Lin LP, et al. Complete sequence and organization of the human cardiac beta-myosin heavy chain gene. Nucleic Acids Res 1990; 18: 3647-3651.
10. Watkins H. Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management. Eur Heart J Suppl 2001; 3 Suppl L: L43-L50.
11. Schwarts K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation 1995; 91: 532-540.
12. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial. hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701-712.
13. Rayment I, Holden HM, Whittaker M, Yohn CB, Lorenz M, Holmes KC, et al. Structure of the actin-myosin complex and its implications for muscle contraction. Science 1993; 261: 58-65.
14. Lowey S. Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. Trends Cardiovasc Med 2002; 12: 348-354.
15. Enjuto M, Francino A, Navarro-Lopez F, Viles D, Pare JC, Ballesta AM. Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in β-myosin heavy chain gene. J Moll Cell Cardiol 2000; 32: 2307-2313.
16. Zou YB, Wang JZ, Wu PX, Zheng WY, Lu SL, Hui RT, et al. Ala26Val mutation in beta - myosin heavy chain gene: a hot spot mutation in Chinese hypertrophic cardiomyopathy Chin J Cardiol (Chin) 2002; 30: 473-476.
17. Song L, Xu R, Wu GR, Wang JZ, Zheng WY, Zou YB, et al. The genotype-phynotype correlation of the beta-myosin heavy chain gene Arg663Cys and Arg663His mutation in familial hypertrophic cardiomyopathy. Chin J Cardiol (Chin) 2002; 30: 131-135.
18. Song L, Huang XH, Hui RT, Gao JH, Zheng WY, Teng SY, at al. Mutations in the gene encoding for cardiac beta-myosin heavy chain in Chinese families with hypertrophic cardiomyopathy. Chin J Cardiol (Chin) 2001; 29: 348-352.
19. Kuang SQ, Yu JD, Lu L, He RM, Gong LS, Chen SJ, et al. Missense mutation in the cardiac β-myosin heavy chain gene in patient with hypertrophic cadiomyopathy. Chin J Cardiol (Chin) 1996; 24: 111-114.
20. Xie WL, Liu WL, Hu DY, Cui W, Zhu TG, Fan DY, et al. Mutations in beta myosin heavy chain gene: one mutation lle736Thr identified firstly in Chinese with hypertrophic cardiomyopathy and the correlation between their genotype and phynotype. Chin J Cardiol (Chin) 2004; 12: 1087-1089.
21. Huang XH, Song L, Ma AQ, Gao JH, Zheng WY, Zhou XL, et al. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gin cardiac beta-myosin heavy-chain mutation in a Chinese family. Clinica Chimica Acta 2001; 310: 131-139.